Senores Pharma Shares Skyrocket 8% on Acquiring 14 ANDAs from Dr Reddy’s
Shares of Senores Pharmaceuticals Ltd skyrocketed 8% on 4 March after the company announced that they had acquired 14 Abbreviated New Drug Applications (ANDAs) from...
Tag : Dr Reddy’s Laboratories
Dr Reddy’s Laboratories Receives VAI Classification from USFDA; Shares Trade Lower
Shares of Dr Reddy’s Laboratories Ltd (DRL) were trading in the red after the company announced that it had obtained an Establishment Inspection Report (EIR)...
Dr Reddy’s Atomoxetine Capsule Import and Sale Suspended in China, Shares Drop 2%
Shares of Dr Reddy’s Laboratories Ltd. dropped by nearly 2% after reaching a day’s high of Rs 7,074.95 on 2nd September, following the suspension of...
Dr Reddy’s to Consider Stock Split on 27 July, Shares Trading Flat
Shares of Dr Reddy’s Laboratories Ltd. are trading flat after touching a day’s high of Rs 6,938.90 on 24 July, after the company announced a...
Dr Reddy’s Lab Surge 3% on Signing Agreement to Acquire Haleon Plc’s Global Portfolio
Shares of Dr Reddy’s Laboratories surged 3% on 27 June after the company announced signing an agreement to acquire UK-based Haleon Plc’s global portfolio of...
Dr Reddy’s Lab Shares Trade Higher as Subsidiary Inks a Licence Agreement
Shares of Dr Reddy’s Laboratories Ltd were trading in the green and 1% higher on 13 June after the company’s subsidiary announced signing a licensing...
Sun Pharma, Dr Reddy’s, and Aurobindo Pharma Recall Products in the US
Drug manufacturers Sun Pharma, Dr Reddy’s, and Aurobindo Pharma are recalling their products in the United States of America market due to manufacturing issues, according to...
Dr Reddy’s Lab Reportedly Plans to Acquire Novartis India, Both Shares Hit 52-week High
Shares of Novartis India and Dr Reddy’s Laboratories hit fresh 52-week highs after reports surfaced suggesting that Dr Reddy’s plans to acquire Switzerland-based pharma company...
Dr Reddy’s Shares Hit 52-Week High on Receiving VAI Status from USFDA
Shares of Dr Reddy’s Laboratories Ltd hit a 52-week high of Rs 6,388.45 on 12 February after USFDA (US Food and Drug Administration) cleared its...
Dr Reddy’s Laboratories Plunged 7% as USFDA Issued Observations for Telangana Unit
Shares of Dr Reddy’s Laboratories Plummeted 7% on 11 December after the USFDA (US Food and Drug Administration) issued three observations for its unit in...
